Be Ready for a New Omalizumab (Xolair) Indication

Omalizumab (Xolair) may pop up on more home med lists.

We’re used to seeing omalizumab used for indications such as allergic asthma.

Now it’s the first monoclonal antibody approved for food allergies.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote